Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.

Indian Heart J. 2011 May-Jun;63(3):211-27. Review.

PMID:
22734339
[PubMed - indexed for MEDLINE]
2.

Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis.

Galper BZ, Moran A, Coxson PG, Pletcher MJ, Heidenreich P, Lazar LD, Rodondi N, Wang YC, Goldman L.

Circulation. 2012 Jan 17;125(2):260-70. doi: 10.1161/CIRCULATIONAHA.111.041293. Epub 2011 Dec 5.

PMID:
22144567
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Neyt M, De Laet C, Van Brabandt H, Franco O, Ramaekers D.

Acta Cardiol. 2009 Feb;64(1):1-10. Review.

PMID:
19317290
[PubMed - indexed for MEDLINE]
4.

Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.

Fidan D, Unal B, Critchley J, Capewell S.

QJM. 2007 May;100(5):277-89. Epub 2007 Apr 21.

PMID:
17449875
[PubMed - indexed for MEDLINE]
Free Article
5.

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis.

Gaziano TA, Opie LH, Weinstein MC.

Lancet. 2006 Aug 19;368(9536):679-86. Review.

PMID:
16920473
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.

Marshall T.

Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):523-8.

PMID:
16874140
[PubMed - indexed for MEDLINE]
7.

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis.

Pignone M, Earnshaw S, Tice JA, Pletcher MJ.

Ann Intern Med. 2006 Mar 7;144(5):326-36.

PMID:
16520473
[PubMed - indexed for MEDLINE]
8.

Summaries for patients. The cost-effectiveness of aspirin, statins, or both drugs in the primary prevention of heart disease.

[No authors listed]

Ann Intern Med. 2006 Mar 7;144(5):I29. No abstract available.

PMID:
16520469
[PubMed - indexed for MEDLINE]
9.

[Primary prevention of coronary heart disease? What is cost effective in the clinical practice?].

K├╝bler W.

Z Kardiol. 2005;94 Suppl 3:III/92-9. German.

PMID:
16258799
[PubMed - indexed for MEDLINE]
10.

[The polypill: optimal strategy for reduction of cardiovascular disease].

Nathoe HM, Doevendans PA.

Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1740. Dutch.

PMID:
16114290
[PubMed - indexed for MEDLINE]
11.

Implementing guidelines in primary care: can population impact measures help?

Heller RF, Edwards R, McElduff P.

BMC Public Health. 2003 Jan 23;3:7. Epub 2003 Jan 23.

PMID:
12542840
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Primary nutritional and drug prevention of atherosclerosis].

Monnier L, Avignon A, Colette C, Piperno M.

Rev Med Interne. 1999 Aug;20 Suppl 3:360s-370s. Review. French.

PMID:
10480187
[PubMed - indexed for MEDLINE]
13.

Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.

Troche CJ, Tacke J, Hinzpeter B, Danner M, Lauterbach KW.

Eur Heart J. 1998 Apr;19 Suppl C:C59-65. Review.

PMID:
9597427
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk